Feb 10, 2026 · Semaglutide belongs to the drug class called GLP-1 receptor agonists.

Dec 6, 2017 · Semaglutide is a glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular …

While Ozempic is the blockbuster medication everyone’s talking about weight loss, the active ingredient – semaglutide – is part of a class of medications that work in a similar way.

Semaglutide is a glucagon-like peptide-1 receptor agonist. [13][14][15] The drug decreases blood sugar levels. The decrease is theorized to be caused by the mimicking of glucagon-like peptide-1 (GLP-1), …

Feb 5, 2025 · Type 2 Diabetes Mellitus therapy has evolved over the years to now include a new class of therapeutics, semaglutide. This article reviews the mechanism of action and formulation of …

Dec 1, 2025 · Semaglutide is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, which is a type of incretin mimetic. These drugs work by mimicking the natural incretin hormone GLP-1, …

Jul 17, 2025 · Physiological implications: Semaglutide is a synthetic analog of human GLP-1, designed to resist degradation by DPP-4 enzyme, enhancing its half-life and efficacy. GLP-1 receptor agonist: …

Semaglutide is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of insulin when blood sugar levels are high.

Ozempic® (semaglutide) injection is a once-weekly GLP-1 RA medicine that, along with diet and exercise, may help improve blood sugar in adults with type 2 diabetes. Read Important Safety …

Jul 1, 2025 · Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the action of the natural hormone GLP-1, which is produced in …